孙鲁宁，博士、副主任药师、副教授、硕士生导师。
主持国家自然科学基金1项，参与国家和省级基金5项、兴卫工程重点项目1项、国家和省级重大专项3项；参与新药临床试验50余项；发表学术论文60余篇，其中以第一或通讯作者发表SCI收录论文20篇。
学术兼职：多个SCI收录杂志审稿人；担任江苏省及国家GCP检查员、中国药理学会临床试验专委会青委会委员、中国药学会新型冠状病毒肺炎药物临床研究数据安全监查委员会秘书、江苏省毒理学会临床安全用药与临床毒理学专业委员会委员、江苏省药理学会临床试验第三方稽查委员会秘书。
目前研究方向：体内药物分析、新药I期临床试验、基于药物代谢的药物相互作用与不良反应研究等工作。
近3年发表的SCI收录论文：
Jian Ren#, Chang-Liang Hu, Zheng-Ping Zhang, Rong Chen, Shi-Bao Yang, Zhen-Yu Miao, Lu-Ning Sun*, Yong-Qing Wang*. Development and validation an LC-MS/MS method to quantify (+)-borneol in rat plasma: Application to a pharmacokinetic study. J Chromatogr B, 1109 (2019) 121-127.
Yi Qian#, Lu-Ning Sun#, Yang-Jie Liu, Qiang Zhang, Jiang-Hao Xu, Zeng-Qing Ma, Xue-Hui Zhang, Hao Xu*, Yong-Qing Wang*. Genetic Polymorphisms and Adverse Events on Unbound Imatinib and Its Active Metabolite Concentration in Patients with Gastrointestinal Stromal Tumors. Front Pharmacol, 2019,10: 854.
Lei Yu#, Lu-Ning Sun#, Xue-Hui Zhang, Yue-Hua Xu, Hong-Wen Zhang, Yi-Wen Shen, Li-Jun Xie, Mei-Feng Wang, Hui-Wen Jiao, Yue-Qi Li, Yong-Qing Wang*, Yun Liu*. Comparison of the gastric acid inhibition function among lansoprazole, pantoprazole, and their respective stereoisomers in healthy Chinese subjects.Int J Clin Pharmacol Ther, 2019, 57(11): 552-560.
Yi Qian#, Lei Yu#, Xue-Hui Zhang, Zi-Qing-Yun Yuan, Ping Zhao, Lu-Ning Sun*, Yong-Qing Wang*. Genetic Polymorphism on the Pharmacokinetics and Pharmacodynamics of Platelet-derived Growth Factor Receptor (PDGFR) Kinase Inhibitors. Curr Drug Metab. 2018, (10): 1-14.
Lu-ning Sun#, Yi-wen Shen#, Yu-wen Ying, Li Duo, Teng-fei Li, Xue-hui Zhang, Ping Zhao, Li Ding*, Yong-qing Wang*. Stereoselective pharmacokinetics of (R)-(+)- and (S)-(-)-rabeprazole in human using chiral LC-MS/MS after administration of rabeprazole sodium enteric-coated tablet. Chirality, 2018, 30(12): 1277-1286.
Hui-Wen Jiao#, Lu-Ning Sun#, Yue-Qi Li, Lei Yu, Hong-Wen Zhang, Mei-Feng Wang, Li-Yuan Yu, Zi-Qing-Yun Yuan, Li-Jun Xie, Juan Chen, Ling Meng, Xue-Hui Zhang, Yong-Qing Wang*. Safety, pharmacokinetics, and pharmacodynamics of S-(-)-pantoprazole sodium injections after single and multiple intravenous doses in healthy Chinese subjects. Eur J Clin Pharmaco, 2018, 74(3): 257-265.
Teng-Fei Li#, Zhi-Min Cui#, Yan Wang, Wen Yang, Duo Li, Qin-Xin Song, Lu-Ning Sun*, Li Ding*. A simple LC-MS/MS method for determination of deferasirox in human plasma: Troubleshooting of interference from ferric ion in method development and its application. J Pharm Biomed Anal, 2018, 151: 145-150.
Yan Wang#, Lan-Ting Zhao, Teng-Fei Li, Wen Yang, Qian Li, Lu-Ning Sun*, Li Ding*. Pharmacokinetics and tissue distribution study of clevidipine and its primary metabolite H152/81 in rats. Biomed Chromatogr, 2018, 32(2): e4048.
Hui-Wen Jiao#, Yue-Qi Li#, Lu-Ning Sun*, Hong-Wen Zhang, Li-Yuan Yu, Lei Yu, Zi-Qing-Yun Yuan, Li-Jun Xie, Juan Chen, Yong-Qing Wang*. A chiral LC-MS/MS method for the enantioselective determination of R-(+)- and S-(-)-pantoprazole in human plasma and its application to a pharmacokinetic study of S-(-)-pantoprazole sodium injection. Biomed Chromatogr, 2017, 31(10): e3980.
Yue-Qi Li#, Zheng-Yu Yan#, Hong-Wen Zhang, Lu-Ning Sun*, Hui-Wen Jiao, Mei-Feng Wang, Li-Yuan Yu, Lei Yu, Zi-Qing-Yun Yuan, Ling Meng, Yong-Qing Wang*. Safety, tolerability, pharmacokinetics and pharmacodynamics of dexlansoprazole injection in healthy Chinese subjects. Eur J Clin Pharmacol, 2017, 73(5): 547-554.
Lu-Ning Sun#, Yang Cao#, Yue-Qi Li, Yun-Qian Fang, Hong-Wen Zhang, Mei-Feng Wang, Li-Jun Xie, Juan Chen, Zhi-Cheng Yang, Ming-Liang Bian, Hao Li, Pei-Pei Zhang, Ji-Fu Wei, Ling Meng, Xue-Hui Zhang, Ping Zhao, Yong-Qing Wang*. Impact of Gastric H+/K+-ATPase rs2733743 on the Intragastric pH-Values of Dexlansoprazole Injection in Chinese Subjects. Front Pharmacol, 2017, 8: 670.
